Self-efficacy and health-related quality of life: a cross-sectional study of primary care patients with multi-morbidity.


Journal

Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626

Informations de publication

Date de publication:
14 Feb 2019
Historique:
received: 09 11 2018
accepted: 03 02 2019
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 21 3 2019
Statut: epublish

Résumé

Multi-morbidity in chronic long-term conditions is a major concern for health services. Self-management in concert with clinical care forms part of the effective management of multi-morbidity. Self-efficacy is a mechanism through which self-management can be achieved. Quality of life is adversely impacted by multi-morbidity but could be improved by effective self-management. This study examines the relationship between self-efficacy and quality of life in primary care patients with multi-morbidity. A cross-sectional survey was conducted with primary care patients in England. Potential participants were mailed a questionnaire containing quality of life measures (the EQ-5D-5L and the Long-Term Conditions Questionnaire (LTCQ)), the Disease Burden Impact Scale (DBIS) and the Self-efficacy for Managing Chronic Disease Scale. Descriptive statistics, analysis of variance and linear regression analyses were conducted to examine the relationship between quality of life (dependent variable), self-efficacy, and demographic and disease-related variables. The 848 participants living with multi-morbidity reported a mean of 6.46 (SD 3.49) chronic long-term conditions, with the mean number of physical conditions 5.99 (SD 3.34) and mental health conditions 0.47 (SD 0.66). The mean scores were 15.45 (SD 12.00) for disease burden, 0.69 (SD 0.28) for the EQ-5D-5L, 65.44 (SD 23.66) for the EQ-VAS, and 69.31 (SD 21.77) for the LTCQ. The mean self-efficacy score was 6.69 (SD 2.53). The regression models were all significant at p < 0.001 (adjusted R Multi-morbid primary care patients with lower self-efficacy and higher disease burden have lower quality of life. Awareness of self-efficacy levels among patients with multi-morbidity may help health professionals identify patients who are in need of enhanced self-management support. Providing self-management support for chronic disease has been hailed as a hallmark of good care. Higher self-efficacy may lead to enhanced quality of life in multi-morbidity.

Sections du résumé

BACKGROUND BACKGROUND
Multi-morbidity in chronic long-term conditions is a major concern for health services. Self-management in concert with clinical care forms part of the effective management of multi-morbidity. Self-efficacy is a mechanism through which self-management can be achieved. Quality of life is adversely impacted by multi-morbidity but could be improved by effective self-management. This study examines the relationship between self-efficacy and quality of life in primary care patients with multi-morbidity.
METHODS METHODS
A cross-sectional survey was conducted with primary care patients in England. Potential participants were mailed a questionnaire containing quality of life measures (the EQ-5D-5L and the Long-Term Conditions Questionnaire (LTCQ)), the Disease Burden Impact Scale (DBIS) and the Self-efficacy for Managing Chronic Disease Scale. Descriptive statistics, analysis of variance and linear regression analyses were conducted to examine the relationship between quality of life (dependent variable), self-efficacy, and demographic and disease-related variables.
RESULTS RESULTS
The 848 participants living with multi-morbidity reported a mean of 6.46 (SD 3.49) chronic long-term conditions, with the mean number of physical conditions 5.99 (SD 3.34) and mental health conditions 0.47 (SD 0.66). The mean scores were 15.45 (SD 12.00) for disease burden, 0.69 (SD 0.28) for the EQ-5D-5L, 65.44 (SD 23.66) for the EQ-VAS, and 69.31 (SD 21.77) for the LTCQ. The mean self-efficacy score was 6.69 (SD 2.53). The regression models were all significant at p < 0.001 (adjusted R
CONCLUSIONS CONCLUSIONS
Multi-morbid primary care patients with lower self-efficacy and higher disease burden have lower quality of life. Awareness of self-efficacy levels among patients with multi-morbidity may help health professionals identify patients who are in need of enhanced self-management support. Providing self-management support for chronic disease has been hailed as a hallmark of good care. Higher self-efficacy may lead to enhanced quality of life in multi-morbidity.

Identifiants

pubmed: 30764833
doi: 10.1186/s12955-019-1103-3
pii: 10.1186/s12955-019-1103-3
pmc: PMC6376655
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

37

Références

Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
Ann Behav Med. 2003 Aug;26(1):1-7
pubmed: 12867348
BMC Health Serv Res. 2013 Mar 26;13:117
pubmed: 23530744
Patient Relat Outcome Meas. 2016 Aug 30;7:109-25
pubmed: 27621678
Adv Ther. 2016 Aug;33(8):1440-51
pubmed: 27357639
Health Qual Life Outcomes. 2004 Sep 20;2:51
pubmed: 15380021
SAGE Open Med. 2013 Oct 26;1:2050312113510001
pubmed: 26770690
Behav Med. 2013;39(1):1-6
pubmed: 23398269
Ann Fam Med. 2018 Mar;16(2):132-138
pubmed: 29531104
Public Health Rep. 2004 May-Jun;119(3):239-43
pubmed: 15158102
Eff Clin Pract. 2001 Nov-Dec;4(6):256-62
pubmed: 11769298
BMC Health Serv Res. 2014 Aug 27;14:356
pubmed: 25164529
J Comorb. 2016 Feb 17;6(1):4-11
pubmed: 29090166
J Clin Epidemiol. 2009 May;62(5):550-7.e1
pubmed: 18757178
JAMA. 2012 Jun 20;307(23):2493-4
pubmed: 22797447
BMJ. 2015 Jan 20;350:h176
pubmed: 25646760
BMJ Open. 2017 Jul 2;7(6):e013664
pubmed: 28674127
Health Econ. 2018 Jan;27(1):7-22
pubmed: 28833869
Health Promot Pract. 2005 Apr;6(2):148-56
pubmed: 15855284
PLoS One. 2010 Dec 29;5(12):e15941
pubmed: 21209965
Psychol Rev. 1977 Mar;84(2):191-215
pubmed: 847061
Qual Life Res. 2015 Apr;24(4):909-18
pubmed: 25344816
Disabil Rehabil. 2006 Jul 15-30;28(13-14):841-7
pubmed: 16777771
BMJ Open. 2017 Nov 3;7(11):e019235
pubmed: 29101153
Biomed Res Int. 2016;2016:7845438
pubmed: 27069925
J Eval Clin Pract. 2013 Feb;19(1):39-43
pubmed: 21883720
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Epidemiol Community Health. 2007 Mar;61(3):254-61
pubmed: 17325405
Eur J Cardiovasc Nurs. 2016 Apr;15(2):186-94
pubmed: 26701344
Scand J Psychol. 2012 Aug;53(4):333-9
pubmed: 22680700
Pharmacoeconomics. 2012 May;30(5):431-42
pubmed: 22452633
Health Qual Life Outcomes. 2017 Jan 9;15(1):7
pubmed: 28069026
BMC Public Health. 2016 Jul 27;16:649
pubmed: 27464646
BMJ Open. 2014 Feb 21;4(2):e003968
pubmed: 24561495
Public Health Rep. 2011 Jul-Aug;126(4):460-71
pubmed: 21800741
Med Care. 2001 Nov;39(11):1217-23
pubmed: 11606875
Int J Nurs Stud. 2015 Mar;52(3):744-55
pubmed: 25468131
J Clin Epidemiol. 2014 Nov;67(11):1265-73
pubmed: 25091546
Health Qual Life Outcomes. 2005 Sep 01;3:51
pubmed: 16137329

Auteurs

Michele Peters (M)

Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK. michele.peters@dph.ox.ac.uk.

Caroline M Potter (CM)

Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.

Laura Kelly (L)

Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.

Ray Fitzpatrick (R)

Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH